LMT503 First-in-human SAD, MAD, and FE Study

Clinical trial NCT05659953 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05659953
Sponsor: Lmito Therapeutics Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Disease Colitis, Ulcerative Crohn Disease

Start date: 2025-04-01
Primary completion: 2025-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.